binx health, a healthcare technology and diagnostics company, announced today the appointment of Jack Crowley as Chief Financial Officer (CFO). Crowley brings deep industry expertise in life sciences and demonstrated results in successful initial and secondary public offerings, capital structure enhancements, analyst collaboration, and investor relations.


“We are thrilled to welcome Jack to our leadership team,” said Jeff Luber, binx CEO. “Whether at PricewaterhouseCoopers, Thermofisher Scientific, Biogen, Lantheus Medical Imaging, or PGDx, Jack has consistently demonstrated the ability to build great finance teams, lead in high-growth environments, and deliver on commitments, quarter after quarter. It’s these talents, and his clear sense of purpose, that will help us in delivering on our vision of ‘everywhere care.’”


“binx health has a vision for healthcare delivery that addresses current gaps in healthcare equity and healthcare access,” said Crowley. “This is a unique and transformational approach. I am appreciative of the opportunity and excited to work with this strong team to help realize this vision and expand upon it.”


Before joining binx health, Crowley was the CFO of Ora, Inc, a global leader in full service ophthalmic research. Jack also served as CFO at Personal Genome Diagnostics and Lantheus Medical Imaging and has held management-level finance positions with Biogen, Thermofisher Scientific and PricewaterhouseCoopers. Crowley is a CPA, MBA and a graduate of University of Massachusetts and Westfield State University. During his career Crowley has distinguished himself as a results-driven finance executive while working for Fortune 500 and private equity backed companies.


Source: binx health

«« The Impact of Staffing Shortages on Patient Safety


UK Healthcare Workforce Recovery After the COVID-19 Pandemic »»



Latest Articles

binx health,Life Sciences, Veteran Jack Crowley ,Chief Financial Officer,healthcare technology,CFO binx health, a healthcare technology and diagnostics company, announced today the appointment of Jack Crowley as Chief Financial Officer (CFO). Crowley brings deep industry expertise in life sciences and demonstrated results in successful initial and seco